Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 22 | 2 | 4 | 0 | €17.55 | €54.83 | 212.410% |
| Ironwood Pharmaceuticals | 9 | 1 | 0 | 0 | €3.56 | €18.27 | 413.202% |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €5.60 | €58.50 | 944.643% |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.75 | - | - |
| Orasure Tech | 3 | 1 | 0 | 0 | €3.76 | €8.36 | 122.295% |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €0.95 | - | - |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| QuidelOrtho Corp. | 8 | 2 | 1 | 0 | €39.60 | €56.55 | 42.795% |
| Actinium Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €1.60 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 9 | 0 | 1 | €0.22 | €14.66 | 6565.591% |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.63 | €5.49 | 775.104% |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.32 | - | - |
| Waters Corp. | 0 | 6 | 0 | 0 | €318.10 | €265.52 | -16.529% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.33 | €10.66 | 701.632% |
| Minerva Neurosciences Inc. | 0 | 13 | 0 | 4 | €2.44 | - | - |
| Organovo Holdings Inc. | 0 | 10 | 0 | 2 | €0.39 | - | - |
| Elanco Animal Health Inc. | 10 | 2 | 2 | 0 | €12.28 | €17.10 | 39.269% |
| Cellectar BioSciences Inc. | 4 | 5 | 0 | 1 | €1.72 | €14.75 | 757.721% |
| Biogen Inc. | 54 | 2 | 4 | 0 | €174.20 | €278.47 | 59.858% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.55 | - | - |
| Trevena Inc. | 2 | 25 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.42 | €23.82 | 271.172% |
| Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.45 | €5.47 | 1120.058% |